Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience

Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience

Objectives: This study describes the clinical outcomes and therapeutic drug monitoring (TDM) following posaconazole suspension pre-emptive therapy in lung transplant (LTx) recipients. Methods: This was a single-centre, retrospective cohort study evaluating posaconazole suspension pre-emptive therapy...

Full description

Bibliographic Details
Main Authors: Ivulich, S. (Author), Jeong, W. (Author), Kong, D.C.M (Author), Levvey, B.J (Author), Neoh, C.F (Author), Orla Morrissey, C. (Author), Slavin, M.A (Author), Snell, G.I (Author), Westall, G.P (Author)
Format: Article
Language:English
Published: Oxford University Press 2017
Subjects:
adult
Adult
antifungal agent
Antifungal Agents
Article
aspergillosis
Aspergillosis
Aspergillus fumigatus
Aspergillus niger
Aspergillus terreus
blood
clinical article
clinical effectiveness
clinical outcome
cohort analysis
Cohort Studies
drug effects
drug monitoring
Drug Monitoring
drug tolerability
drug withdrawal
eradication therapy
female
Female
fungal colonization
fungus isolation
Fusarium
graft recipient
human
Humans
isolation and purification
liver dysfunction
lung transplantation
Lung Transplantation
male
Male
microbiology
middle aged
Middle Aged
minimum plasma concentration
nausea
nonhuman
observational study
Paecilomyces
posaconazole
Retrospective Studies
retrospective study
Scedosporium apiospermum
Scopulariopsis
suspension
Suspensions
Transplant Recipients
treatment outcome
Treatment Outcome
triazole derivative
Triazoles
vomiting
voriconazole
Voriconazole
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items